Price

$ 234.47

return (12m)

85.47% Logo

p/e

14.65

p/bv

2.30

DIVIDEND YIELD

0.00%
graph

THC price

THC
If you had invested
If you had invested
years ago
7 days
30 days
6 months
YTD
1 year
5 years
10 years
ago, you would now have *
ago, you would now have:
*
*The figure considers the reinvestment of dividends.

Return on Investment THC

1 month
3 months
1 year
2 years
5 years
10 years
return
1 month
21.51%
3 months
18.59%
1 year
85.47%
2 years
141.55%
5 years
0.00%
10 years
0.00%
Estatistica

Fundamentals THC

review the fundamentals of Tenet Healthcare Corporation shares

P/E

14.65
Sector: 8.39 Industry: 8.39

P/S (PSR)

0.97
Sector: 2.40 Industry: 2.40

P/BV

2.30
Sector: 2.04 Industry: 2.04

DIVIDEND YIELD (DY)

0.00%
Sector: 0.69% Industry: 0.69%

ROA

4.74%
Sector: 0.20% Industry: 0.20%

ROE

15.68%
Sector: 5.00% Industry: 5.00%

ROIC

13.11%
Sector: -136.87% Industry: -136.87%

NET MARGIN

6.60%
Sector: 2.89% Industry: 2.89%

GROSS MARGIN

82.26%
Sector: 31.30% Industry: 31.30%

OPERATING MARGIN

16.14%
Sector: 4.55% Industry: 4.55%

EV/EBITDA

4.60
Sector: 3.15 Industry: 3.15

EV/EBIT

5.69
Sector: 1.95 Industry: 1.95

PRICE-TO-ASSETS

0.69
Sector: 1.02 Industry: 1.02

BVPS

103.14
Sector: 9.42 Industry: 9.42

EPS

16.17
Sector: 0.67 Industry: 0.67

EQUITY-TO-ASSETS RATIO

0.30
Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.70
Sector: 0.51 Industry: 0.51

CAGR REVENUE 5 YEARS

1.81%
Sector: - Industry: -

CAGR PROFIT 5 YEARS

9.01%
Sector: - Industry: -
RETORNO DO INVESTIMENTO

FAIR VALUE OF Tenet Healthcare Corporation ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 234.47

Fair Value

$ 0.00

Upside/Downside Return potential.

-17.38%
Because it considers equity value in its calculation, this formula may not work well for technology companies.
This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.
statistics

Fundamentals THC

Buy And Hold Investor Checklist

Tenet Healthcare Corporation Buy And Hold Investor Checklist

Stock Comparison Tool

graph

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.
Price

THC Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type

Ex - Dividend Date

payment date

value

Dividend 03/15/2000 03/24/2000 0,02666667

ABOUT

Logo Tenet Healthcare Corporation

Tenet Healthcare Corporation

Average Investor10 user rating

4.0 (5 people)

United States

United States

- year

Founded:

Time since IPO - - year

-

Employees

Market cap

$ 20.61 Billions

$ 20.61 Billions

Net worth

$ 8.97 Billions

US$ 8,973,000,000.00

Assets

$ 29.68 Billions

US$ 29,677,000,000.00

Total Shares Outstanding

87.00 Millions

87,000,000

Average Daily Trading Volume

$ 978.34 Thousand

US$ 978,337.64

Sector

Others

Industry

Others

Shares

receitas e lucros

THC revenue and profits

resultados

Financial Results THC

DRAG THE FRAME TO SEE MORE DATA
Resultados

THC cash flow

DRAG THE FRAME TO SEE MORE DATA
Ativos e Passivos

Asset, Revenue and Profit Growth - THC

Pontos Relevantes

THC balance sheet

DRAG THE FRAME TO SEE MORE DATA

Frequently Asked Questions

What is the price of Tenet Healthcare Corporation (THC) today?

The price of Tenet Healthcare Corporation (THC) today is $ 234.47, with return of 85.47% compared to the last year. The price of Tenet Healthcare Corporation (THC) started the year trading around $ 198.72 and today it is at $ 234.47. Follow the real-time price chart, the historical price of Tenet Healthcare Corporation (THC) and international markets.

When does Tenet Healthcare Corporation (THC) pay dividends?

Tenet Healthcare Corporation (THC) did not distribute dividends in the last year.

Is Tenet Healthcare Corporation (THC) worth it?

Currently, Tenet Healthcare Corporation (THC) is priced at $ 234.47, with a P/E of 14.65%, representing a deviation of 459% from its historical average P/E. In the last year, the stock showed a variation of 85.47 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 85.47%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Tenet Healthcare Corporation (THC) stock?

Investing in stocks of Tenet Healthcare Corporation (THC) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Tenet Healthcare Corporation (THC) yield today?

The yield of Tenet Healthcare Corporation (THC) was 21.51% in the last month, 85.47% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Tenet Healthcare Corporation (THC) today, the total investment would be $ 23,447.00, based on the current price of $ 234.47.

If past performance were to repeat, the return on your investment would be:

  • In 1 year: $ 43,487.15
  • In 5 years: $ 23,447.00
  • In 10 years: $ 23,447.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.